Atlas Trials

Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System

Clinical trial NCT02663323 · UNKNOWN

Trial details

NCT number
NCT02663323
Sponsor
Meril Life Sciences Pvt. Ltd.
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Coronary Artery Disease
Start date
2016-02-02
Primary completion
2017-10-05
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.